Edwards Lifesciences: $20 Billion TAM And A Meaningful Opportunity To Compound (NYSE:EW)
· seekingalpha.com
Baron Asset Fund initiated a position in Edwards Lifesciences due to its dominant heart valve market share. Read the full analysis for more details.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...